Skip to content
10-Q

Quarterly Report

ESCALON MEDICAL CORP ESMC

0000862668-22-000026

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Nov 10, 2022 7.42M sh
Stockholders Equity Q1 2023 · Sep 30, 2022 $1.16M
Stockholders Equity Q1 2023 · Sep 30, 2021 $1.78M
Stockholders Equity Q1 2023 · Jun 30, 2021 $1.46M
Current Liabilities Q1 2023 · Sep 30, 2022 $3.16M
Current Liabilities Q1 2023 · Jun 30, 2022 $3M
Total Liabilities Q1 2023 · Sep 30, 2022 $3.77M
Total Liabilities Q1 2023 · Jun 30, 2022 $3.69M
Current Assets Q1 2023 · Sep 30, 2022 $4.02M
Current Assets Q1 2023 · Jun 30, 2022 $4.19M
Total Assets Q1 2023 · Sep 30, 2022 $4.93M
Total Assets Q1 2023 · Jun 30, 2022 $5.17M
Shares Diluted Q1 2023 · Sep 30, 2021 12.88M sh
Operating Cash Flow Q1 2023 · Sep 30, 2021 −$393.39K
Cash And Equivalents Q1 2023 · Sep 30, 2021 $1.26M
Cash And Equivalents Q1 2023 · Jun 30, 2021 $1.65M
Eps Diluted Q1 2023 · Sep 30, 2021 $0.02
Eps Basic Q1 2023 · Sep 30, 2021 $0.04
Sga Expense Q1 2023 · Sep 30, 2021 $904.49K
Rd Expense Q1 2023 · Sep 30, 2021 $291.19K
Net Income Q1 2023 · Sep 30, 2021 $317.22K
Operating Income Q1 2023 · Sep 30, 2021 −$184.49K
Cost Of Revenue Q1 2023 · Sep 30, 2021 $1.66M